# Current checkpoint

## What's done

- Issue #47 remains on `feat/47-record-provider-denied-authorization` from exact `dev@013959a5c0e018f22a0cba9933b3622c2219629d`; Draft PR #190 and every remote action remain Commander-owned.
- The provider-free Task authorization implementation and permanent J-03 are unchanged. Exact implementation head `173b2f617bf98b570e976abed32e3372841266d4` previously passed the pinned Windows `doctor` → `bootstrap` → `build` → `e2e:all` sequence for J-01/J-02/J-08/J-12/J-15/J-03. Later commits through `85e64c5aae9627116d5ee272073a27ff9c969567` changed routing documentation only.
- Paired Hosted Gate run `33704901249` checked exact head `85e64c5aae9627116d5ee272073a27ff9c969567`. Its macOS job failed at the payload-safe but overly broad `J-01/review` marker; fail-fast cancelled the paired Windows job. No later Journey or Hosted completion is claimed.
- The permanent exact-path J-01 diagnostic passed twice on Windows at the affected head and after the bounded diagnostic change. The Issue #47 J-01 product delta is limited to the exact preload-key assertion, which executes before `review` and therefore passed in the failing Hosted run.
- Source inspection found that the initial review renderer is constructed synchronously after its preparation IPC completes, while the only asynchronous review mutation—degradation acceptance—already has a bounded wait. The runner's `review` marker instead remained active across review-contract assertions, acceptance, the commit click, and durable completion, and was reused by multiple clean setup imports. Existing evidence therefore does not identify a product defect or justify a speculative product/timeout change.
- The permanent J-01 runner and controller now admit payload-safe `review-contract`, `review-acceptance`, `commit`, and `completion` markers for the prior default `review` path. Existing continuity and interruption scenario markers remain unchanged. Build and the targeted J-01 diagnostic pass locally.
- Exact diagnostic head `ab0ed6d90eda2bad19769f6fc16dbde66dec47f7` passed the pinned Windows 11 x64 `doctor` → `bootstrap` → `build` → `e2e:all` sequence with Node 24.18.1, pnpm 11.24.0, and Electron 43.4.1. J-01/J-02/J-08/J-12/J-15/J-03 all passed with `LOCAL_COMPLETION/all/pass`.
- Cleanup left zero newly created Journey roots, zero owned Node/Electron processes, and zero non-dependency reparse points. Older unrelated temporary roots were not modified.

## What's next

- Commander owns branch push, Draft PR #190 update, review/Ready handling, and any paired Hosted Gate rerun. Only a new safe marker from that rerun can distinguish a macOS product failure from a transient timing/test incident.

## Key decisions

- Do not change product behavior or lengthen timeouts without a reproducing boundary. The current evidence is two local passes plus a Hosted marker that spans several distinct operations.
- Diagnostic names expose only lifecycle stages. They contain no manuscript, source, identifier, payload, path, credential, Provider, model, or artifact data.
- Issue #47 authority remains provider-free and record-only; no Provider, secret read, Session, scheduler, payload, egress, network, recording, model execution, or Effect path is entered.

## Unresolved matters or blockers

- The exact macOS cause remains unclassified because the old `review` marker discarded the necessary boundary. There is no local product-scope or structural-budget blocker; Hosted evidence remains incomplete and Commander-owned.

## Safe Resume Prompt

```text
Commander: receive Issue #47 from locally validated diagnostic head ab0ed6d90eda2bad19769f6fc16dbde66dec47f7 plus its final routing-doc commit, push the branch, and rerun the paired Hosted Gate. Classify any macOS recurrence only from the new payload-safe J-01 review-contract/review-acceptance/commit/completion marker; do not infer payload details, broaden product behavior, or enter Provider/secret/session/scheduler/egress/model/Effect paths.
```
